Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-018523

Options or other derivatives

  • Director acquired 22,916 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Van Hauwermeiren Timothy Director 2025-06-26 Grant or award · Stock Option (right to buy) +22,916 22,916 D
Loading xslF345X05/form4-06302025_050614.xml…